Molecular epidemiology of tuberculosis in the Tula area, Central Russia, before the introduction of the Directly Observed Therapy Strategy

Clinical Microbiology and Infection

Volumn 16, Issue 9, 2010, Pages 1421-1426

  Dubiley, S ^a,b   Ignatova, A ^a   Mukhina, T ^b   Nizova, A ^b   Blagodatskikh, S ^b   Stepanshina, V ^b   Shemyakin, I ^b  

^a SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^b STATE RESEARCH CENTER FOR APPLIED MICROBIOLOGY AND BIOTECHNOLOGY   (Russian Federation)

Author keywords

Epidemiology; Lineage; Multi drug resistance; Prison; Strain; Tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM DETECTION; BACTERIUM ISOLATE; EPIDEMIOLOGICAL DATA; GENOTYPE; HUMAN; MICROBIAL DIVERSITY; MOLECULAR EPIDEMIOLOGY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RUSSIAN FEDERATION; TUBERCULOSIS;

MYCOBACTERIUM TUBERCULOSIS;

EID: 77956125377     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.03102.x     Document Type: Article

References (26)

1. Global tuberculosis control - surveillance, planning, financing. http://www.who.int/tb/publications/global_report/2008, WHO Report 2008.
2. Zignol M, Hosseini MS, Wright A. Global incidence of multidrug-resistant tuberculosis. J Infect Dis 2006, 194:479-485.
3. Chaulk CP, Kazandjian VA. Directly observed therapy for treatment completion of pulmonary tuberculosis: consensus Statement of the Public Health Tuberculosis Guidelines Panel. JAMA 1998, 279:943-948.
4. Balabanova Y, Ruddy M, Hubb J. Multidrug-resistant tuberculosis in Russia: clinical characteristics, analysis of second-line drug resistance and development of standardized therapy. Eur J Clin Microbiol Infect Dis 2005, 24:136-139.
5. Perelman MI, Mikhailova YV. Tuberculosis in the Russian Federation. An analytical review of the main tuberculosis statistical indicators used in the Russian Federation 2008, eds, WHO, Moscow
6. Ignatova A, Dubiley S, Stepanshina V, Shemyakin I. Predominance of multi-drug-resistant LAM and Beijing family strains among Mycobacterium tuberculosis isolates recovered from prison inmates in Tula Region, Russia. J Med Microbiol 2006, 55:1413-1418.
7. Kent PT, Kubica GP. Public Health Mycobacteriology. A Guide for the Level III Laboratory 1985, Atlanta, GA, Centers for Disease Control and Prevention
8. van Soolingen D, Hermans PW, De Haas PE, Soll DR, van Embden JD. Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis. J Clin Microbiol 1991, 29:2578-2586.
9. van Embden JD, Cave MD, Crawford JT. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology. J Clin Microbiol 1993, 31:406-409.
10. Kamerbeek J, Schouls L, Kolk A. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J Clin Microbiol 1997, 35:907-914.
11. Dubiley S, Mayorova A, Ignatova A. New PCR-based assay for detection of common mutations associated with rifampin and isoniazid resistance in Mycobacterium tuberculosis. Clin Chem 2005, 51:447-450.
12. Filliol I, Motiwala AS, Cavatore M. Global phylogeny of Mycobacterium tuberculosis based on single nucleotide polymorphism (SNP) analysis: insights into tuberculosis evolution, phylogenetic accuracy of other DNA fingerprinting systems, and recommendations for a minimal standard SNP set. J Bacteriol 2006, 188:759-772.
13. Prod'hom G, Guilhot C, Gutierrez MC, Varnerot A, Gicquel B, Vincent V. Rapid discrimination of Mycobacterium tuberculosis complex strains by ligation-mediated PCR fingerprint analysis. J Clin Microbiol 1997, 35:3331-3334.
14. Hazbón MH, Bobadilla del Valle M, Guerrero MI. Role of embB codon 306 mutations in Mycobacterium tuberculosis revisited: a novel association with broad drug resistance and IS6110 clustering rather than ethambutol resistance. Antimicrob Agents Chemother 2005, 49:3794-3802.
15. Starks AM, Gumusboga A, Plikaytis BB, Shinnick TM, Posey JE. Mutations at embB306 are an important molecular indicator of ethambutol resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2009, 53:1061-1066.
16. Brudey K, Driscoll JR, Rigouts L. Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiol 2006, 6:23.
17. Dubiley S, Kirillov E, Ignatova A, Stepanshina V, Shemyakin I. Molecular characteristics of the Mycobacterium tuberculosis LAM-RUS family prevalent in Central Russia. J Clin Microbiol 2007, 45:4036-4038.
18. Keshavjee S, Gelmanova IY, Pasechnikov AD. Treating multidrug-resistant tuberculosis in Tomsk, Russia: developing programs that address the linkage between poverty and disease. Ann NY Acad Sci 2008, 1136:1-11.
19. Global tuberculosis control - surveillance, planning, financing. http://www.who.int/tb/publications/global_report/2004/RussianFederation.pdf, WHO Report 2004.
20. Glynn JR, Whiteley J, Bifani PJ, Kremer K, van Soolingen D. Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. Emerg Infect Dis 2002, 8:843-849.
21. Johnson R, Warren R, Strauss OJ. An outbreak of drug-resistant tuberculosis caused by a Beijing strain in the western Cape, South Africa. Int J Tuberc Lung Dis 2006, 10:1412-1414.
22. Toungoussova OS, Sandven P, Mariandyshev AO, Nizovtseva NI, Bjune G, Caugant DA. Spread of drug-resistant Mycobacterium tuberculosis strains of the Beijing genotype in the Archangel Oblast, Russia. J Clin Microbiol 2002, 40:1930-1937.
23. Drobniewski F, Balabanova Y, Nikolayevsky V. Drug-resistant tuberculosis, clinical virulence, and the dominance of the Beijing strain family in Russia. JAMA 2005, 293:2726-27231.
24. Coker R, McKee M, Atun R. Risk factors for pulmonary tuberculosis in Russia: case-control study. BMJ 2006, 332:85-87.
25. Story A, Murad S, Roberts W, Verheyen M, Hayward AC. Tuberculosis in London: the importance of homelessness, problem drug use and prison. Thorax 2007, 62:667-671. London Tuberculosis Nurses Network
26. Fry RS, Khoshnood K, Vdovichenko E. Barriers to completion of tuberculosis treatment among prisoners and former prisoners in St. Petersburg, Russia. Int J Tuberc Lung Dis 2005, 9:1027-1033.